In vitroCharacterization of a small molecule inhibitor of the alanine serine cysteine transporter -1 (SLC7A10)

Neuronal D-Serine and Glycine Release Via the Asc-1 Transporter Regulates NMDA Receptor-Dependent Synaptic Activity

(2013) D. Rosenberg et al.   JOURNAL OF NEUROSCIENCE

Multiple risk pathways for schizophrenia converge in serine racemase knockout mice, a mouse model of NMDA receptor hypofunction

(2013) D. T. Balu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

A novel glycine transporter-1 (GlyT1) inhibitor, ASP2535 (4-[3-isopropyl-5-(6-phenyl-3-pyridyl)-4H-1,2,4-triazol-4-yl]-2,1,3-benzoxadiazole), improves cognition in animal models of cognitive impairment in schizophrenia and Alzheimer's disease

(2012) Katsuya Harada et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Meta-Analysis of the Efficacy of Adjunctive NMDA Receptor Modulators in Chronic Schizophrenia

(2011) Surendra P. Singh et al.   CNS DRUGS

Blockade of glycine transporter 1 by SSR-504734 promotes cognitive flexibility in glycine/NMDA receptor-dependent manner

(2011) Agnieszka Nikiforuk et al.   NEUROPHARMACOLOGY

High dose D-serine in the treatment of schizophrenia

(2010) Joshua T. Kantrowitz et al.   SCHIZOPHRENIA RESEARCH

Cellular distribution of the neutral amino acid transporter subtype ASCT2 in mouse brain

(2008) Catherine M. Gliddon et al.   JOURNAL OF NEUROCHEMISTRY

Procognitive and antipsychotic efficacy of glycine transport 1 inhibitors (GlyT1) in acute and neurodevelopmental models of schizophrenia: latent inhibition studies in the rat

(2008) Mark D. Black et al.   PSYCHOPHARMACOLOGY